[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100591135":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":24,"centralContacts":25,"locations":31,"responsibleParty":42,"collaborators":24,"id":44,"slug":45,"hasResults":46,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":24,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":52,"minAge":53,"maxAge":24,"enrollmentInfo":54,"targetDuration":24,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":24,"overallStatus":63,"whyStopped":24,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Addpharma Inc.","INDUSTRY",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Sequence A","EXPERIMENTAL","Period 1: Fasted, Period 2: Fed",[13],"Drug: PA-111",{"label":15,"type":10,"description":16,"interventionNames":17},"Sequence B","Period 1: Fed, Period 2: Fasted",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"DRUG","PA-111","PA-111 1Tab., Per Oral",[9,15],null,[26],{"name":27,"role":28,"phone":29,"phoneExt":24,"email":30},"JeongEun Park","CONTACT","+82-31-891-6989","parkje@addpharma.co.kr",[32],{"facility":33,"status":24,"city":34,"state":24,"zip":24,"country":35,"countryCode":24,"cosmosGeoPoint":36,"geoPoint":41,"contacts":24},"H Plus Yangji Hospital","Seoul","South Korea",{"type":37,"coordinates":38},"Point",[39,40],126.9784,37.566,{"lat":40,"lon":39},{"type":43,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR","100591135","phase-1-the-food-effect-on-pk-characteristics-and-safety-profiles-of-pa-111-100591135",false,"NCT06976489","The Food Effect on PK Characteristics and Safety Profiles of PA-111","An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Food Effect on the Safety and the Pharmacokinetics of PA-111 in Healthy Adult Volunteers","Inclusion Criteria:\n\n* Body weight equal to or greater than 50kg (Female 45kg) and Body mass index (BMI) between 18.0 kg\u002Fm2 and 30.0 kg\u002Fm2 at the time of screening visit\n* The Age equal to or greater than 19 in healthy volunteers at the time of screening visit\n\nExclusion Criteria:\n\n* Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration\n* Other exclusions applied",true,"ALL","19 Years",{"count":55,"type":56},40,"ESTIMATED","INTERVENTIONAL",[59],"PHASE1","Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of PA-111 in healthy subjects.",[62],"Mixed Dyslipidemia","NOT_YET_RECRUITING","2025-05-09",{"date":66,"type":67},"2025-05-16","ACTUAL",{"date":69,"type":56},"2025-05",{"date":71,"type":56},"2025-07",{"name":5,"class":6},1]